The latest on the coronavirus pandemic and vaccines
A trial in South Africa of an experimental coronavirus vaccine made by US vaccine maker Novavax shows the vaccine is about 50% effective against a variant that's now the dominant s…
A trial in South Africa of an experimental coronavirus vaccine made by US vaccine maker Novavax shows the vaccine is about 50% effective against a variant that's now the dominant s…